MRVI NASDAQ
Maravai LifeSciences Holdings, Inc.
1W: +14.7%
1M: +8.3%
3M: +25.3%
YTD: +142.9%
1Y: +142.2%
3Y: +19.5%
5Y: -79.3%
$8.26
+0.68 (+8.97%)
Weekly Expected Move ±11.1%
$6
$7
$7
$8
$9
Credit Risk of going bust: higher than 50% of companies Debt: 7.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.07 (down 99.1%), Maravai LifeSciences Holdings, Inc. would be worth roughly what it owes.
Total debt $176.7M against a stock market value of $2.34B.
Distance to default 5.09 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $74.1M (short-term plus half of long-term), stock volatility 67.1%; Altman Z'' 0.85. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.07 (down 99.1%), Maravai LifeSciences Holdings, Inc. would be worth roughly what it owes.
Total debt $176.7M against a stock market value of $2.34B.
Distance to default 5.09 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $74.1M (short-term plus half of long-term), stock volatility 67.1%; Altman Z'' 0.85. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
8 relationships8
As Filer
counterparties named
0
As Counterparty
mentioned by others
5
Rel. Types
2021-08-10
Earliest Filing
2021-09-03
Latest Filing
target: 2
acquirer: 2
customer: 2
investor: 1
supplier: 1
Counterparties (Filed by MRVI)
8 relationshipsCompanies named in MRVI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Vector Laboratories, Inc. | — | target | Target of the sale of the Protein Detection business segment | 2021-09-03 | View |
| Voyager Group Holdings, Inc. | VOYG | acquirer | Acquirer of the Protein Detection business segment | 2021-09-03 | View |
| Thompson Street Capital Partners VI, L.P. | — | investor | Affiliated entity with the acquirer Voyager Group Holdings, Inc. | 2021-09-03 | View |
| TriLink Biotechnologies, LLC | — | supplier | Supplier entering into an amended supply agreement | 2021-09-03 | View |
| Pfizer Inc. | PFE | customer | Counterparty to the amended supply agreement | 2021-09-03 | View |
| BioNTech SE | BNTX | customer | Counterparty to the amended supply agreement | 2021-09-03 | View |
| Vector Laboratories, Inc. | — | target | Sale of Protein Detection business segment | 2021-08-10 | View |
| Voyager Group Holdings, Inc. | VOYG | acquirer | Acquired Protein Detection business segment | 2021-08-10 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-06-03 | Material Agreement; Termination of Agreement; Financial Obligation; Regulation FD; Exhibits | Agreement | View |
| 2026-05-29 | Shareholder Vote | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-02-25 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-27 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-11 | Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; De | View | |
| 2025-07-18 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-06-25 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-06-09 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-05-28 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-20 | Regulation FD Disclosure | View | |
| 2025-03-18 | Results of Operations and Financial Condition; Non-Reliance on Previously Issued Financial Statement | View | |
| 2025-02-25 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-01-08 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2024-12-18 | Other Events | View | |
| 2024-12-05 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure | View | |
| 2024-11-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR